Profile data is unavailable for this security.
About the company
Jagsonpal Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is primarily engaged in the manufacturing and trading of pharmaceutical products and active pharmaceutical ingredients (APIs). Its Gynaecology products include Divatrone, Endoreg, Cystelia-M, Fibristone, Yuliprist, Deereg, and Lycored Softgel. Its Orthopaedics products include JP Tone Up, Metadec 50 Injection, Metadec 25 Injection, Indocap SR, and Indocap, Colla-2. Its other products include Equirex, Doxypal DR-L, JP Tone Syrup, and Lycored Syrup.
- Revenue in INR (TTM)2.27bn
- Net income in INR243.00m
- Incorporated1978
- Employees1.03k
- LocationJagsonpal Pharmaceuticals LtdT 210J, ShahpurjatGURGAON 122015IndiaIND
- Phone+91 1 244406710
- Fax+91 1 126494708
- Websitehttps://www.jagsonpal.com/
More ▼
Mergers & acquisitions
| Acquired company | JAGSNPHARM:NSI since announced | Transaction value |
|---|---|---|
| Yash Pharma Laboratories Pvt Ltd-Indian Business | 78.70% | -- |
| Yash Pharma Laboratories Pvt Ltd-Bhutan Business | 78.70% | 11.09m |
Data delayed at least 15 minutes, as of Nov 21 2024 10:00 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kopran Ltd | 6.36bn | 528.93m | 10.03bn | 358.00 | 15.68 | 2.02 | 14.86 | 1.58 | 13.26 | 13.26 | 150.57 | 103.15 | 0.8922 | 2.76 | 3.64 | 17,765,300.00 | 7.42 | 8.47 | 10.49 | 12.23 | 35.38 | 32.93 | 8.32 | 8.89 | 1.27 | 29.83 | 0.1997 | 25.41 | 11.54 | 11.42 | 87.11 | 16.23 | 12.53 | -- |
| Ngl Fine Chem Ltd | 3.72bn | 413.64m | 11.05bn | 390.00 | 26.72 | 3.94 | 29.05 | 2.97 | 66.95 | 66.95 | 601.51 | 453.70 | 1.03 | 4.37 | 5.12 | 9,529,503.00 | 11.51 | 15.06 | 14.90 | 19.58 | 51.59 | 43.53 | 11.13 | 13.15 | 2.17 | 25.70 | 0.1594 | 3.06 | 21.79 | 17.20 | 101.58 | 15.47 | 14.49 | 0.00 |
| Bajaj Healthcare Ltd | 5.08bn | -101.06m | 12.42bn | 944.00 | -- | 2.78 | 68.66 | 2.44 | -3.70 | -5.69 | 183.39 | 141.16 | 0.6186 | 1.54 | 2.33 | 5,379,316.00 | -1.23 | 7.67 | -2.35 | 14.11 | 47.51 | 33.26 | -1.99 | 7.99 | 1.21 | 1.95 | 0.3158 | 4.90 | -26.69 | 5.04 | -122.55 | -- | 15.08 | -- |
| Lincoln Pharmaceuticals Ltd | 5.97bn | 966.39m | 12.49bn | 1.70k | 12.92 | 1.95 | 11.50 | 2.09 | 48.25 | 48.25 | 298.31 | 319.16 | 0.828 | 3.77 | 3.40 | 3,514,339.00 | 13.39 | 13.95 | 15.85 | 16.54 | 52.60 | 50.65 | 16.18 | 14.71 | 3.64 | 60.48 | 0.0021 | 3.44 | 13.76 | 9.66 | 27.99 | 13.88 | 21.54 | 3.71 |
| Bliss GVS Pharma Ltd | 8.00bn | 634.20m | 12.71bn | 831.00 | 20.30 | 1.26 | 12.76 | 1.59 | 5.94 | 5.94 | 75.55 | 96.05 | 0.6454 | 3.10 | 1.98 | 9,628,987.00 | 5.80 | 6.46 | 7.04 | 8.22 | 50.26 | 43.91 | 8.99 | 9.92 | 3.74 | -- | 0.0825 | 7.92 | 2.48 | -3.03 | 6.49 | -9.42 | -8.33 | -12.94 |
| Remus Pharmaceuticals Ltd | 2.12bn | 215.37m | 13.88bn | 48.00 | 63.11 | 15.99 | 51.67 | 6.53 | 37.34 | 37.34 | 374.91 | 147.42 | 1.46 | 7.61 | 3.56 | 44,270,750.00 | 17.80 | -- | 44.48 | -- | 22.67 | -- | 12.22 | -- | 1.12 | 55.56 | 0.0997 | -- | 371.94 | -- | 153.29 | -- | -- | -- |
| Zota Health Care Ltd | 1.98bn | -242.34m | 14.72bn | 445.00 | -- | -- | 3,152.02 | 7.43 | -9.27 | -9.27 | 76.32 | -- | -- | -- | -- | 4,452,605.00 | -- | -1.38 | -- | -1.85 | 49.86 | 35.95 | -12.23 | -1.33 | -- | -2.87 | -- | -- | 28.96 | 16.08 | -148.54 | -- | 39.85 | 0.00 |
| Jagsonpal Pharmaceuticals Ltd | 2.27bn | 243.00m | 15.29bn | 1.03k | 64.24 | 7.75 | 53.59 | 6.74 | 8.98 | 8.98 | 83.78 | 74.42 | 0.9703 | 5.13 | 9.92 | 2,213,181.00 | 10.39 | 10.95 | 12.40 | 13.29 | 58.16 | 58.13 | 10.71 | 9.21 | 2.60 | 32.84 | 0.0474 | 43.81 | -11.83 | 4.58 | -15.94 | 25.50 | -35.69 | 82.06 |
| JG Chemicals Ltd | 7.57bn | 550.05m | 16.18bn | 56.00 | 27.97 | 3.71 | 25.94 | 2.14 | 14.77 | 14.77 | 202.34 | 111.33 | -- | -- | -- | 135,230,700.00 | -- | -- | -- | -- | 17.29 | -- | 7.56 | -- | 11.46 | -- | 0.0281 | -- | -14.90 | -- | -43.84 | -- | -- | -- |
| Sigachi Industries Ltd | 4.36bn | 660.99m | 16.60bn | 991.00 | 29.53 | 3.52 | 21.35 | 3.81 | 1.69 | 1.69 | 11.11 | 14.15 | 0.6266 | 3.01 | 3.27 | 4,396,491.00 | 9.36 | 14.77 | 13.25 | 19.57 | 50.50 | 50.30 | 14.93 | 14.92 | 1.39 | 6.47 | 0.2576 | 1.61 | 32.08 | 25.34 | 31.34 | 24.64 | 70.35 | -- |
| Syncom Formulations (India) Ltd | 3.29bn | 331.47m | 18.97bn | 802.00 | 49.71 | 6.05 | 49.28 | 5.76 | 0.406 | 0.406 | 3.49 | 3.34 | 0.8485 | 6.21 | 3.62 | 4,105,761.00 | 8.54 | 7.50 | 10.99 | 10.23 | 38.49 | 34.10 | 10.07 | 9.38 | 4.09 | 12.05 | 0.0435 | -- | 17.45 | 7.12 | 26.13 | 17.95 | -- | -- |
| Beta Drugs Ltd | 3.35bn | 410.00m | 19.37bn | 371.00 | 47.25 | 10.71 | 37.95 | 5.79 | 42.65 | 42.65 | 348.21 | 188.13 | 1.26 | 4.04 | 3.74 | 9,022,873.00 | 15.42 | 15.10 | 23.35 | 22.23 | 39.95 | 39.77 | 12.25 | 12.38 | 1.59 | 17.06 | 0.0953 | 0.00 | 30.21 | 35.01 | 18.62 | 35.29 | -10.89 | -- |
| Windlas Biotech Ltd | 6.96bn | 612.28m | 20.04bn | 1.15k | 32.84 | 4.25 | 24.79 | 2.88 | 29.20 | 29.20 | 331.88 | 225.63 | 1.06 | 6.07 | 4.43 | 6,028,180.00 | 9.30 | -- | 13.64 | -- | 37.52 | -- | 8.80 | -- | 1.61 | 30.61 | 0.0388 | -- | 22.97 | -- | 36.51 | -- | -- | -- |
| IOL Chemicals and Pharmaceuticals Ltd. | 20.72bn | 1.19bn | 20.62bn | 2.78k | 17.39 | -- | 11.15 | 0.9953 | 20.20 | 20.20 | 353.05 | -- | -- | -- | -- | 7,461,253.00 | -- | 14.91 | -- | 19.45 | 33.96 | 34.54 | 5.72 | 12.00 | -- | 10.06 | -- | 10.59 | -3.80 | 4.82 | -3.39 | -10.70 | 35.27 | -- |
Data as of Nov 21 2024. Currency figures normalised to Jagsonpal Pharmaceuticals Ltd's reporting currency: Indian Rupee INR
0.00%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| WhiteOak Capital Asset Management Ltd.as of 31 Oct 2024 | 0.00 | 0.00% |
Data from 31 Oct 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
